BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 29309307)

  • 1. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
    Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
    Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelioid Soft Tissue Neoplasm of the Soft Palate with a PTCH1-GLI1 Fusion: A Case Report and Review of the Literature.
    Klubíčková N; Kinkor Z; Michal M; Baněčková M; Hájková V; Michálek J; Pink R; Dvořák Z; Michal M; Leivo I; Skálová A
    Head Neck Pathol; 2022 Jun; 16(2):621-630. PubMed ID: 34655412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericytoma With t(7;12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of GLI1 Fusion-related Neoplasms.
    Kerr DA; Pinto A; Subhawong TK; Wilky BA; Schlumbrecht MP; Antonescu CR; Nielsen GP; Rosenberg AE
    Am J Surg Pathol; 2019 Dec; 43(12):1682-1692. PubMed ID: 31567194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Malignant Neoplasm From the Jejunum With a
    Prall OWJ; McEvoy CRE; Byrne DJ; Iravani A; Browning J; Choong DY; Yellapu B; O'Haire S; Smith K; Luen SJ; Mitchell PLR; Desai J; Fox SB; Fellowes A; Xu H
    Int J Surg Pathol; 2020 Aug; 28(5):553-562. PubMed ID: 31931637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions.
    Agaram NP; Zhang L; Sung YS; Singer S; Stevens T; Prieto-Granada CN; Bishop JA; Wood BA; Swanson D; Dickson BC; Antonescu CR
    Mod Pathol; 2019 Nov; 32(11):1617-1626. PubMed ID: 31189998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis.
    Kerr DA; Cloutier JM; Margolis M; Mata DA; Rodrigues Simoes NJ; Faquin WC; Dias-Santagata D; Chopra S; Charville GW; Wangsiricharoen S; Lazar AJ; Wang WL; Rosenberg AE; Tse JY
    Mod Pathol; 2024 Feb; 37(2):100386. PubMed ID: 37992966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous epithelioid mesenchymal neoplasm with ACTB-GLI1 fusion: a case report.
    Rollins BT; Cassarino DS; Lindberg M
    J Cutan Pathol; 2022 Mar; 49(3):284-287. PubMed ID: 34643288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis.
    Xu B; Chang K; Folpe AL; Kao YC; Wey SL; Huang HY; Gill AJ; Rooper L; Bishop JA; Dickson BC; Lee JC; Antonescu CR
    Am J Surg Pathol; 2020 Jun; 44(6):729-737. PubMed ID: 31934916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
    Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
    Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.
    Jessurun J; Orr C; McNulty SN; Hagen CE; Alnajar H; Wilkes D; Kudman S; Al Assaad M; Dorsaint P; Ohara K; He F; Chiu K; Yin YM; Xiang JZ; Qin L; Sboner A; Elemento O; Yantiss RK; Graham RP; Poizat F; Mosquera JM
    Am J Surg Pathol; 2023 Jan; 47(1):65-73. PubMed ID: 35968961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma.
    Banerjee S; Corless CL; Miettinen MM; Noh S; Ustoy R; Davis JL; Tang CM; Yebra M; Burgoyne AM; Sicklick JK
    J Transl Med; 2019 Jul; 17(1):246. PubMed ID: 31362756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTCH1-GLI1 Fusion-Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib.
    Alwaqfi RR; Samuelson MI; Guseva NN; Ouyang M; Bossler AD; Ma D
    J Natl Compr Canc Netw; 2021 Sep; 19(9):998-1004. PubMed ID: 34551385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma.
    Spans L; Fletcher CD; Antonescu CR; Rouquette A; Coindre JM; Sciot R; Debiec-Rychter M
    J Pathol; 2016 Jul; 239(3):335-43. PubMed ID: 27101025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature.
    Cohen JN; Sabnis AJ; Krings G; Cho SJ; Horvai AE; Davis JL
    Hum Pathol; 2018 Nov; 81():281-290. PubMed ID: 29626598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm With Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations.
    Papke DJ; Dickson BC; Sholl L; Fletcher CDM
    Am J Surg Pathol; 2022 Jan; 46(1):33-43. PubMed ID: 34081037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLI1-altered epithelioid soft tissue tumor: A newly described entity with a predilection for the tongue.
    Zhong H; Xu C; Chen X; Guo X; Yang S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jul; 134(1):e14-e22. PubMed ID: 35165054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
    Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
    Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity.
    Liu J; Mao R; Lao IW; Yu L; Bai Q; Zhou X; Wang J
    Virchows Arch; 2022 May; 480(5):1087-1099. PubMed ID: 34779913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Cutaneous Epithelioid Mesenchymal Tumor With a Novel ATP2B4::GLI1 Gene Fusion.
    Rezaee N; Cohen B; Eno C; Shon W
    Am J Dermatopathol; 2023 Sep; 45(9):642-645. PubMed ID: 37506273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.